Naproxen: Proceedings from an International Medical Symposium Presented by Syntex Corporation 7-8 May 1973, Geneva, SwitzerlandKenneth Dumas |
Contents
Introduction | 5 |
Pharmacological Properties of Naproxen | 12 |
Comparative Toxicology of Naproxen | 20 |
8 other sections not shown
Common terms and phrases
acid activity administration analgesic aspirin assessment Behandlung better blood casos changes clínica clinical clinique compared comparison complete daily dans decrease deux difference disease dolor dose dosis double-blind drug duration efectos efficacy eine enfermos estudio étude evaluation examination Fälle four given human hyperemia Ibuprofen included increased indomethacin joint jour laboratory levels malades mean measured medication ment method moderate months morning stiffness naproxen normal objective observed occurred ont été oral pain parameters Patienten patients period phase placebo plasma Posible present rats received recorded reported response resultados résultats rheumatic rheumatoid arthritis Rheumatology roxen seen severe shown shows side effects significant statistically subjects successful symptoms Table therapeutic therapy tients tion tolerated traitement tratamiento treated treatment trial values Versuch weeks wurde wurden